VOLUME
65 2004 NUMBER 2
CME Pretest 146
CME Posttest 283
Publisher's Note
147 Medical Education: Our Mission and Our Success.
[PDF]
Consensus Statement
267 Consensus Development Conference on Antipsychotic Drugs
and Obesity and Diabetes.
[PDF]
Brainstorms
149 Psychopharmacology of Anticonvulsants: Do All
Anticonvulsants Have the Same Mechanism of Action? Stephen M.
Stahl
[PDF]
Original Articles
151 Benzodiazepine Prescription Practices and Substance Abuse
in Persons With Severe Mental Illness. Robin E. Clark, Haiyi
Xie, and Mary F. Brunette
[Abstract]
[PDF]
156 Limbic Paroxysmal Magnetoencephalographic Activity in 12
Obsessive-Compulsive Disorder Patients: A New Diagnostic Finding.
Carlos Amo, L. Felipe Quesney, Tomás Ortiz, Fernando Maestú,
Alberto Fernández, Maria Inés López-Ibor, and Juan José
López-Ibor
[Abstract]
[PDF]
163 Defining Remission on the Montgomery-Asberg Depression
Rating Scale. Mark Zimmerman, Michael A. Posternak, and Iwona
Chelminski
[Abstract]
[PDF]
169 Depressive Disorders Are Related to Nicotine Dependence in
the Population But Do Not Necessarily Hamper Smoking Cessation. [CME] Ulrich John, Christian
Meyer, Hans-Jürgen Rumpf, and Ulfert Hapke
[Abstract]
[PDF]
177 Lithium for Schizophrenia Revisited: A Systematic Review
and Meta-Analysis of Randomized Controlled Trials. Stefan
Leucht, Werner Kissling, and John McGrath
[Abstract]
[PDF]
187 Cabergoline Treatment of Risperidone-Induced
Hyperprolactinemia: A Pilot Study. Roberto Cavallaro, Federica
Cocchi, Sara M. Angelone, Enrico Lattuada, and Enrico Smeraldi
[Abstract]
[PDF]
191 Musical Hallucinations: Prevalence in Psychotic and
Nonpsychotic Outpatients. Haggai Hermesh, Shai Konas, Roni
Shiloh, Reuven Dar, Sofi Marom, Abraham Weizman, and Ruth
Gross-Isseroff
[Abstract]
[PDF]
198 Clinical and Legal Correlates of Inmates With Bipolar
Disorder at Time of Criminal Arrest. Cameron D. Quanbeck,
David C. Stone, Charles L. Scott, Barbara E. McDermott, Lori L.
Altshuler, and Mark A. Frye
[Abstract]
[PDF]
204 A 52-Week, Open-Label Continuation Study of Lamotrigine in
the Treatment of Bipolar Depression. Susan L. McElroy, Carlos
A. Zarate, John Cookson, Trisha Suppes, Russell F. Huffman, Paul
Greene, and John Ascher
[Abstract]
[PDF]
211 A Pilot Study of Barriers to Medication Adherence in
Schizophrenia. Teresa J. Hudson, Richard R. Owen, Carol R.
Thrush, Xiaotong Han, Jeffrey M. Pyne, Purushottam Thapa, and
Greer Sullivan
[Abstract]
[PDF]
217 Ziprasidone Augmentation of Selective Serotonin Reuptake
Inhibitors (SSRIs) for SSRI-Resistant Major Depressive Disorder.
George I. Papakostas, Timothy J. Petersen, Andrew A. Nierenberg,
Jessica L. Murakami, Jonathan E. Alpert, Jerrold F. Rosenbaum,
and Maurizio Fava
[Abstract]
[PDF]
222 Controlled-Release Paroxetine in the Treatment of Patients
With Social Anxiety Disorder. Ulla Lepola, Bettina Bergtholdt,
Jane St. Lambert, Katherine L. Davy, and Lee Ruggiero
[Abstract]
[PDF]
230 Pharmacologic Factors Associated With Transient Neonatal
Symptoms Following Prenatal Psychotropic Medication Exposure.
Tim F. Oberlander, Shaila Misri, Colleen E. Fitzgerald, Xanthoula
Kostaras, Dan Rurak, and Wayne Riggs
[Abstract]
[PDF]
238 Pindolol Augmentation in Depressed Patients Resistant to
Selective Serotonin Reuptake Inhibitors: A Double-Blind,
Randomized, Controlled Trial. Edward B. Perry, Jr., Robert M.
Berman, Gerard Sanacora, Amit Anand, Kathleen Lynch-Colonese, and
Dennis S. Charney
[Abstract]
[PDF]
244 Double-Blind, Placebo-Controlled Assessment of Combined
Clonazepam With Paroxetine Compared With Paroxetine Monotherapy
for Generalized Social Anxiety Disorder. Soraya Seedat and
Murray B. Stein
[Abstract]
[PDF]
249 Childhood Maltreatment as a Risk Factor for Adult
Cardiovascular Disease and Depression. Sonja V. Batten,
Mihaela Aslan, Paul K. Maciejewski, and Carolyn M. Mazure
[Abstract]
[PDF]
Academic Highlights
255 Emerging Therapeutic Strategies in Alzheimer's Disease. [CME]
[PDF]
Letters To the Editor
273 Sleep-Related Eating Disorder Induced by Risperidone.
Mong-Liang Lu and Winston W. Shen
[PDF]
274 Potential for Detection Bias in the Association Between
Olanzapine and Diabetes. Michael T. Compton and Holly A. Hill
[PDF]
- Reply by J. Jaime Caro
275 Improvement of Psychosis During Treatment With Estrogen
and Progesterone in a Patient With Hypoestrogenemia. Maria A.
Rettenbacher, Sergei Mechtcheriakov, Anton Bergant, Anita
Brugger, and W. Wolfgang Fleischhacker
[PDF]
277 A Case Report of Mania Related to Discontinuation of
Bupropion Therapy for Smoking Cessation. Nikolaus Michael,
Andreas Erfurth, and Volker Arolt
[PDF]
278 Self-Reported Participation inNonpharmacologic Treatments
for Bipolar Disorder. Ellen B. Dennehy, Robert Gonzalez, and
Trisha Suppes
[PDF]
278 Modafinil and Antipsychotic-Induced Sedation. John R.
DeQuardo
[PDF]
- Reply by Eugene H. Makela
279 Correction. Corya SA, Andersen SW, Detke HC, Kelly LS,
Van Campen LE, Sanger TM, Willamson DJ, Dubé S. Long-term
antidepressant efficacy and safety of olanzapine/fluoxetine
combination: a 76-week open-label study (J Clin Psychiatry
2003;64:1349-1356)
[PDF]
Book Review 280
WorldView of Psychiatry 281
NOW @ Psychiatrist.com 285
Information for authors
see www.psychiatrist.com/author.htm
for complete information